The MIT MAESTRO research seeks to research why some individuals develop continual sickness from acute infections utilizing the lens of each continual Lyme and lengthy COVID – whereas additionally answering one crucial query: Who’s prone to develop continual signs after an infection and why?
The MAESTRO research will recruit 300 adults aged 18-35 throughout 4 distinct cohorts: these with acute Lyme disease, continual Lyme disease, lengthy COVID, and a management group.
In line with the Tal Analysis Group’s web site, “We goal to establish biomarkers that may distinguish people who will or is not going to return to well being and to generate actionable data that may advance scientific care, scientific trials, and future therapeutics.”
Click here to learn more about the study and how you can participate.
SOURCE: Tal Research Group, MIT
